Ticker LaunchReverse merger · Completed · ORKA
Oruka Therapeutics, Inc.
Reverse merger with ARCA biopharma, Inc.
Oruka Therapeutics, Inc. merged into ARCA biopharma, Inc., a Nasdaq-listed biopharma that paid a special cash dividend before merging, in a reverse merger that takes the private company public. The deal was announced on Mar 22, 2024 and closed on Aug 29, 2024. The combined company trades as Oruka Therapeutics, Inc. (ORKA) on Nasdaq.
Oruka Therapeutics develops biologics for chronic skin diseases such as plaque psoriasis, including ORKA-001, an IL-23p19 antibody designed for once- or twice-yearly dosing, and ORKA-002.
- Status
- Completed
- Private company
- Oruka Therapeutics, Inc.
- Public company
- ARCA biopharma, Inc.
- Public company business before
- Nasdaq-listed biopharma that paid a special cash dividend before merging
- Announced
- Mar 22, 2024
- Closed
- Aug 29, 2024
- Combined company
- Oruka Therapeutics, Inc. (ORKA)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Form 8-K (closing) Sep 5, 2024
- Press release (closing)
- Form 8-K (merger agreement) Mar 22, 2024
- All filings on EDGAR CIK 907654
Other completed reverse mergers
- NAYA Biosciences, Inc.into INVO Bioscience, Inc. · Oct 11, 2024
- Pharmagesic (Holdings) Inc. (Wex Pharmaceuticals)into Virios Therapeutics, Inc. · Oct 7, 2024
- OnKure, Inc.into Reneo Pharmaceuticals, Inc. · Oct 4, 2024
- Polomar Specialty Pharmacy, LLCinto Trustfeed Corp. · Sep 30, 2024
- Firefly Neuroscience, Inc.into WaveDancer, Inc. · Aug 12, 2024
- Horizon Kinetics LLCinto Scott's Liquid Gold-Inc. · Aug 1, 2024